-
NSAIDs and cardiovascular risk; new antithrombotic guidelines; warfarin during surgery; Pfizer selling Viagra online; azithromycin and cardiovascular risk; and FDA actions.
-
Subarachnoid hemorrhage (SAH) is a stroke syndrome, defined as rapidly developing neurological dysfunction and/or headache because of bleeding into the subarachnoid space (the space between the subarachnoid membrane and the pia mater of the brain or spinal cord), which is not caused by trauma.1 It is a dire condition with high morbidity and mortality.
-
Despite better compliance with hand hygiene and screening, use of isolation, and other techniques, ICUs remain notorious breeding grounds for hospital-acquired infections. A universal decolonization strategy reduces the total number of ICU bloodborne infections.
-
-
The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial randomized 1376 patients with AF and CHF to rhythm- or rate-control treatment strategies.
-
This study examines the influence of renal dysfunction on stroke risks in two atrial fibrillation (AF) study groups. The ROCKET AF trial was a trial comparing fixed-dose rivaroxaban, a direct factor Xa inhibitor, with adjusted-dose warfarin for prevention of thromboembolic events.
-
Aspirin use and AMD risk; using NSAIDs and antihypertensive agents; and FDA actions.
-
The accurate and timely recognition of acute coronary syndromes (ACS) may facilitate the deployment of evidence-based therapies that could impact outcomes.
-
Beta-blockers are widely considered first-line therapy for heart rate control in patients with permanent atrial fibrillation (AF), but few comparative effectiveness data with other drugs are available.
-
During coronary artery bypass graft (CABG) surgery, the aim is to achieve complete revascularization of all the coronary arteries.
